Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;13(3):331-6.
doi: 10.1016/j.coph.2013.04.010. Epub 2013 May 9.

Anti-viral agents: potential utility in exacerbations of asthma

Affiliations
Review

Anti-viral agents: potential utility in exacerbations of asthma

Jaideep Dhariwal et al. Curr Opin Pharmacol. 2013 Jun.

Abstract

Asthma is the most common chronic respiratory disease and its prevalence is on the increase. Respiratory viral infections in early life have been suggested to increase the risk of development of asthma in later life and virus infection remains the single greatest precipitant of asthma exacerbations. The development of effective anti-viral treatments remains a key target for therapeutic intervention. Here we discuss the role of respiratory viral infection in asthma exacerbation and highlight current and potential anti-viral agents and their mechanisms of action.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Anti-viral approaches may (1) prevent viruses acting in a synergistic or additive manner with allergens, and cause immune deviation to a Th1 rather than Th2 immune response. Anti-viral approaches may be (2) agents that prevent virus infection or replication at mucosal surfaces and prevent epithelial damage, inflammation, mucous production, activation of macrophages and attraction of neutrophils into the lung, which promote further inflammation and damage.

References

    1. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59:469–478. - PubMed
    1. Ivanova J.I. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129:1229–1235. - PubMed
    2. Study comparing direct health care costs between moderate/severe asthmatics with and without exacerbations. Demonstrated that moderate severe asthmatics who had exacerbations had higher total and asthma related health care costs.

    1. Corne J.M. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359:831–834. - PubMed
    1. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982–986. - PMC - PubMed
    1. Chauhan A.J. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet. 2003;361:1939–1944. - PMC - PubMed

MeSH terms

Substances